Fluorine‐18 labelling of oligonucleotides: Prosthetic labelling at the 5′‐end using the N‐(4‐[18F]fluorobenzyl)‐2‐bromoacetamide reagent

Labelled oligonucleotides are new imaging tools to study gene expression at the nucleic acid and protein levels. We have previously developed a universal method to label oligonucleotides at their 3′-end with radiohalogens and particularly with fluorine-18, the most widely used positron-emitter, t1/2: 109.8 min. Using the same strategy, we herein report the fluorine-18 labelling of oligonucleotides at their 5′-end. A 18-mer 2′O-methyl modified oligoribonucleotide, bearing a phosphorothioate group at its 5′-end, was conjugated to our fluorine-18-labelled reagent N-(4-[18F]fluorobenzyl)-2-bromoacetamide. The whole synthetic procedure yielded up to 1 GBq of fluorine-18-labelled oligonucleotide with a specific radioactivity of 37–74 GBq/μmol in 160 min. Copyright © 2003 John Wiley & Sons, Ltd.

[1]  C. Crouzel,et al.  General method to label antisense oligonucleotides with radioactive halogens for pharmacological and imaging studies. , 2000, Bioconjugate chemistry.

[2]  C. Crouzel,et al.  Fluorine-18 labeling of oligonucleotides bearing chemically—modified ribose—phosphate backbones , 2000 .

[3]  C Crouzel,et al.  Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors. , 1999, Journal of medicinal chemistry.

[4]  C. Crouzel,et al.  Synthesis of a fluorine-18 labeled derivative of epibatidine for in vivo nicotinic acetylcholine receptor PET imaging. , 1999, Bioorganic & medicinal chemistry.

[5]  Bernard Bendriem,et al.  In vivo imaging of oligonucleotides with positron emission tomography , 1998, Nature Medicine.

[6]  M. Caruthers,et al.  Comparative pharmacokinetics, tissue distribution, and tumor accumulation of phosphorothioate, phosphorodithioate, and methylphosphonate oligonucleotides in nude mice. , 1997, Antisense & nucleic acid drug development.

[7]  C. Crouzel,et al.  A general method for labeling oligodeoxynucleotides with 18F for in vivo PET imaging , 1997 .

[8]  P. D. Cook,et al.  Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expression. , 1993, The Journal of biological chemistry.

[9]  P. Miller Oligonucleoside Methylphosphonates as Antisense Reagents , 1991, Bio/Technology.

[10]  K. Hamacher,et al.  Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  S. Agrawal,et al.  Pharmacokinetics of Antisense Oligonucleotides , 1995, Clinical pharmacokinetics.